title: Update in management of hepatocellular carcinoma in Eastern population.
abstract: Hepatocellular carcinoma (HCC) is one of the commonest malignant tumours in the East. Although the management of HCC in the West is mainly based on the Barcelona Clinic for Liver Cancer staging, it is considered too conservative by Asian countries where the number of HCC patients is huge. Scientific and clinical advances were made in aspects of diagnosis, staging, and treatment of HCC. HCC is well known to be associated with cirrhosis and the treatment of HCC must take into account the presence and stage of chronic liver disease. The major treatment modalities of HCC include: (1) surgical resection; (2) liver transplantation; (3) local ablation therapy; (4) transarterial locoregional treatment; and (5) systemic treatment. Among these, resection, liver transplantation and ablation therapy for small HCC are considered as curative treatment. Portal vein embolisation and the associating liver partition with portal vein ligation for staged hepatectomy may reduce dropout in patients with marginally resectable disease but the midterm and long-term results are still to be confirmed. Patient selection for the best treatment modality is the key to success of treatment of HCC. The purpose of current review is to provide a description of the current advances in diagnosis, staging, pre-operative liver function assessment and treatment options for patients with HCC in the east.
authors.affiliation: Kevin Ka Wan Chu, Tan To Cheung, Department of Surgery, the University of Hong Kong, Hong Kong, China.
authors.forename: Kevin Ka Wan
authors.initials: KK
authors.lastname: Chu
authors.affiliation: Kevin Ka Wan Chu, Tan To Cheung, Department of Surgery, the University of Hong Kong, Hong Kong, China.
authors.forename: Tan To
authors.initials: TT
authors.lastname: Cheung
keywords: Evidence; Hepatocellular carcinoma; Liver cirrhosis; Management; Survival; Treatment; Update